Robustness of the assay was evaluated through the determination of the Z' factor. The potent inhibitor 2 (1 μM in 10 mM HEPES pH 7.4 buffer containing 1% DMSO, final concentration) and blank 10 mM HEPES pH 7.4 buffer containing 1% DMSO were used as the positive and negative controls, respectively. A pre-incubated mixture (10 μL) of His-tagged Keap1 Kelch domain protein (final, 5 nM) and Tb-anti-His antibody (final, 0.5 nM) was dispensed into wells of a 384-well assay plate already containing 0.2 μL of the inhibitor solution or neat DMSO (33 replicates each). After a 30-min incubation, FITC-9mer Nrf2 peptide amide (final, 25 nM) was added. The assay mixture was further incubated for 1 h before the TR-FRET signals were measured. The Z' factor was calculated using the following equation:
Where and are the standard deviation of the positive and negative control wells, respectively; whereas and are the mean TR-FRET signal values of the positive and negative controls, respectively.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.